JPMorgan $975K Nasdaq‑100 3.125x Leveraged Barrier Notes
JPMorgan Chase Financial Company LLC priced $975,000 of uncapped accelerated barrier notes linked to the Nasdaq-100 Futures Excess Index.
Rhea-AI Filing Summary
JPMorgan Chase Financial Company LLC priced $975,000 of uncapped accelerated barrier notes linked to the Nasdaq-100 Futures Excess Index. The notes, priced on June 1, 2026 with expected settlement on June 4, 2026, pay at maturity based on the Index Return multiplied by an Upside Leverage Factor of 3.125 and feature a Barrier Amount equal to 65.00% of the Initial Value. If the Final Value is below the Barrier Amount, investors suffer a pro rata loss of principal; if at or above the Barrier Amount but not above the Initial Value, investors receive principal only. The Initial Value on the Pricing Date was 806.3630, the Observation Date is June 2, 2036, and the Maturity Date is June 5, 2036. Per‑note original issue price is $1,000 with selling commissions of $2.50; the estimated value at pricing was $965.50 per $1,000 note.
Positive
- None.
Negative
- None.
Insights
Notes offer leveraged upside (3.125x) with full downside principal exposure below a 65% barrier.
The notes provide an amplified return on positive Index performance via a 3.125 Upside Leverage Factor and an uncapped payout formula: $1,000 + ($1,000 × Index Return × 3.125) when Final Value > Initial Value. The Barrier Amount is 65.00% of the Initial Value; if the Index falls below that barrier on the Observation Date, investors incur proportional principal losses.
Key dependencies include the closing level of the Nasdaq-100 Futures Excess Index on the Observation Date, the issuer/guarantor creditworthiness, and limited secondary market liquidity. Pricing shows an estimated value of $965.50 per $1,000 note versus a public price of $1,000, reflecting embedded costs and hedging margins.
Issuer expects U.S. federal tax treatment as an "open transaction," but alternative IRS treatments may apply.
The pricing supplement states the issuer intends to treat the notes as open transactions for U.S. federal income tax purposes, which, if respected, generally yields long‑term capital gain/loss treatment for holders who hold more than one year. The issuer's counsel notes other reasonable treatments could be adopted by the IRS or a court.
Section 871(m) is discussed; the issuer and special tax counsel opine it should not apply to Non‑U.S. Holders for these notes, but that determination is not binding on the IRS. Investors should consult tax advisers; potential alternative characterizations could materially affect timing and character of income.
Key Figures
Key Terms
Upside Leverage Factor financial
Barrier Amount financial
hybrid instrument exemption regulatory
open transaction tax
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What payout does JPMorgan's Nasdaq-100 uncapped accelerated barrier note provide?
When do these JPMorgan notes mature and how long is the term?
What is the Barrier Amount and what happens if the Index falls below it?
How were these notes priced and what is the estimated value at issuance?
Are these notes insured or backed by a bank deposit insurance?
AI-generated analysis. How Rhea-AI works. Not financial advice.